Abstract

Objective: Interferon-γ release tests (IGRAs) and tuberculin skin testing (TST) are important helpful tests for diagnosing tuberculosis (TB) disease in children. It was aimed to compare the sensitivity and compatibility of QuantiFERON-TB Gold In-tube test (QFT) and TST used in children with TB and Latent tuberculosis infection (LTBI).

Material and Methods: A total of 118 patients between September 2018 and January 2020 were included in the study prospectively to determine the case characteristics related to the performance of the tests, and to measure the sensitivity of these tests.

Results: A total of 118 patients were included in the study; and 13 (11%) patients presented with pneumonia symptoms and 7 (6%) patients were diagnosed with TB in active TB Contact Screening. TB diagnosis was made 20% microbiologically. Mycobacterium tuberculosis culture positivity was found to be 10%. None of the patients had acid-resistant bacilli positivity. The male / female rate was 74/44 in our study (p = 0.006). The median age was found to be 14 (1.17-19.2 years) in males, and 12 (0.33 -17.9 years) in females. The mean age of the LTBI Group was higher than the TB Group at significant levels (p <0.05), and was similar to the non-infected group (p>0.05). A total of 53.5% of the patients had a history of meeting someone with tuberculosis, and 97 children were vaccinated with BCG (82.2%). TST and QFT positivities were 19.5% and 22%, respectively. The most common radiological finding that was detected was consolidation areas. While there was moderate compliance between TST and IGRA test in patients with TB diagnosis (kappa =0.50, p=0.025), no compliance was found between tests in LTBI patients. In patients who were diagnosed with TB and LTBI, the sensitivity of TST was found to be 51.1%, and the sensitivity of QFT was found to be 60.4%.

Conclusion: TST seems to continue as the most preferred method of diagnosis in rural areas with limited resources and poor laboratory infrastructure due to the costs and technical considerations.

Keywords: Tuberculosis, Interferon Gamma Release Test, Latent Tuberculosis, Tuberculin Skin Test

References

  1. World Health Organization, Global Tuberculosis Report 2015, World Health Organization, Geneva,Switzerland, 20th edition, 2015,http://www.who.int/tb/publications/global_report/en/.
  2. Kay AW, Islam SM, Wendorf K, Westenhouse J, Barry PM. Interferon-γ release assay performance for tuberculosis in childhood. Pediatrics 2018;141:e29728429.
  3. Graham SM, Cuevas LE, Jean-Philippe P, Browning R, Casenghi M, Detjen AK, et al. Clinical case definitions for classification of intrathoracic tuberculosis in children: an update. Clin Infect Dis 2015; 15: 179-87.
  4. Chiang SS, Starke JR. Mycobacterium Tuberculosis. In: Long SS, Prober CG, Fischer M (eds). Principles and Practice of Pediatric Infectious Disease. 5th ed. Philadelphia: Elsevier 2018:4026-81.
  5. T.C. Ministry of Health Tuberculosis Diagnosis and Treatment Guide Akdağ R. (eds) Ankara 2011.
  6. Mazure GH, Jereb J, LoBue P, Iademarco MF, Vernon A. Guidelines for Using the QuantiFERON®-TB G Test for Detecting Mycobacterium tuberculosis Infection, United States. MMWR Recomm Rep 2005;16:49-55.
  7. Starke JR. Diagnosis of tuberculosis in children. Pediatr Infect Dis J 2000;19:1095–96.
  8. Starke JR. Interferon release assay for diagnosis of tuberculosis infection and disease in children. Pediatrics 2014;134:1763-73.
  9. Ahmed A, Feng PJ, Gaensbauer JT, Reves RR, Khurana R, Salcedo K et al. Interferon-γ release assays in children< 15 years of age. Pediatrics 2020;145:e20191930
  10. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT. TB in children. PloS One 2008;3:2624.
  11. Tavast E, Salo E, Seppälä I, Tuuminen T. IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland. BMC Res Notes 2009;2:9.
  12. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Kambafwile JM, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:45-55.
  13. Togun TO, Egere U, Gomez MP, Sillah AK, Daramy M, Tientcheu LD, et al. No added value of interferon-γ release to a prediction model for childhood tuberculosis. Eur Respir J 2016;47:223-32.
  14. Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, Alier NM, et al. Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009;33:1374-82.
  15. Schepisi MS, Motta I, Dore S, Costa C, Satgiu G, Giordi E. Tuberculosis transmission among children and adolescents in schools and other congreate settings: a systemic rewiew. New Microbiol 2018;41:282-90.
  16. Kim D, Lee S, Kang SH, Park MS, Yoo S, Jeon TY, et al. A contact investigation after exposure to a child with disseminated tuberculosis mimicking inflammatory bowel disease. Korean J Pediatr 2018;61:366-70.
  17. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 2014;27:3-20.

Copyright and license

Copyright © 2022 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Özen S, Üçkardeş F, Uygun H, Erdem N, Akgül N, Turğut M. Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold Test in Children. Turk J Pediatr Dis [Internet]. 2022 Sep. 20 [cited 2025 Aug. 23];16(5):362-7. Available from: https://turkjpediatrdis.org/article/view/845